Biotech Late Stage Investors & VC Firms
90 firms in this list, with a median first check of $4.1M. 25 of them lead rounds. Generated from verified public data and updated continuously.
Venrock
Menlo ParkSeed–Late Stage
TPB
San FranciscoSeed–Late Stage
Ridgeback Capital
MiamiSeed–Late Stage
Alium Capital
SydneySeed–Late Stage
Mérieux Equity Partners
ParisSeed–Late Stage$3.3M – $86.5M
HBM Healthcare Investments
Late Stage
Infotech Ventures
BeijingSeed–Late Stage
Forbion
AmsterdamPre-Seed–Late Stage
Elmirate Capital
DubaiSeed–Late Stage$15M – $150M
BioRock Ventures
Bay AreaSeed–Late Stage
B Capital Group
Pre-Seed–Late Stage
Ambix Venture Management, Llc
Mountain ViewPre-Seed–Late Stage
T. Rowe Price
LondonSeed–Late Stage
Visionaries Club
BerlinPre-Seed–Late Stage
Pappas Capital
DurhamLate Stage
Amgen Ventures
Thousand OaksSeed–Late Stage
Deep Insight
Tel AvivPre-Seed–Late Stage
Gurnet Point Capital
Pre-Seed–Late Stage
Lundbeckfonden Ventures
CopenhagenPre-Seed–Late Stage
Related lists
Late Stage Investors & VC Firms (1479)Biotech Investors & VC Firms (320)Biotech Seed Investors & VC Firms (255)Biotech Series A Investors & VC Firms (228)Biotech Pre-Seed Investors & VC Firms (153)Biotech Series B Investors & VC Firms (148)AI & Machine Learning Late Stage Investors & VC Firms (146)Healthtech Late Stage Investors & VC Firms (118)Biotech Growth Investors & VC Firms (104)Fintech Late Stage Investors & VC Firms (98)
Data sourced from public filings and firms' own websites — see our methodology.